west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "连续性肾脏替代疗法" 2 results
  • 对高龄重症急性肾功能衰竭患者连续性肾脏替代疗法的护理

    目的探讨在连续性肾脏替代疗法(CRRT)中,对高龄重症急性肾功能衰竭(SARF)患者的护理方法。 方法2010年2月-2012年 7月,对收治的 28例高龄 SARF患者行 CRRT治疗后,根据治疗结果分为存活组(22例)和死亡组(6 例),观察两组患者治疗前后心功能、并发症及器官衰竭的数量,总结有针对性的护理对策。 结果在CRRT 治疗中,两组患者在心功能指标和器官衰竭数量比较,差异均有统计学意义(P<0.05)。 结论CRRT 是抢救高龄 SARF 患者的有效方法,并且根据生命体征监测数据制定有针对性的护理措施能够有效地提高其存活率。

    Release date: Export PDF Favorites Scan
  • Efficacy comparison between continuous renal replacement therapy and intermittent hemodialysis in the treatment of severe acute renal failure

    Objective To compare the clinical effect of continuous renal replacement therapy (CRRT) and intermittent hemodialysis (IHD) in the treatment of severe acute renal failure (ARF). Methods A hundred patients with severe ARF treated between May 2011 and December 2014 were chosen to be the study subjects. According to the order of admission, they were divided into control group and observation group with 50 patients in each. Patients of the control group underwent IHD, while those in the observation group underwent CRRT. Serum creatinine (Scr), blood urea nitrogen (BUN), endogenous creatinine clearance rate (Ccr), treatment effective rate and survival rate were compared between the two groups before and after the treatment. Results Scr, BUN and Ccr were all improved after treatment in both the two groups. However, Scr, BUN and Ccr in the observation group [(225.1±162.7) μmol/L, (14.2±9.3) mmol/L, (23.4±10.5) mL/min] were significantly better than those in the control group [(588.4±183.6) μmol/L, (29.1±10.4) mmol/L, (15.9±8.2) mL/min]. The treatment effective rate and patients’ survival rate in the observation group were respectively 60% and 70%, both significantly higher than those in the control group (40% and 52%) All the differences were significant (P<0.05). Conclusion CRRT is superior in the treatment of severe ARF with a higher survival rate of the patients, which is worthy of clinical promotion.

    Release date:2017-03-27 11:42 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content